NCT01907165View on ClinicalTrials.gov

Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 10, 2013

Primary Completion Date

November 10, 2016

Study Completion Date

February 9, 2018

Conditions
Glioblastoma
Interventions
DRUG

Temozolomide

DRUG

Disulfiram

DIETARY_SUPPLEMENT

Copper gluconate

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01907165 - Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide | Biotech Hunter | Biotech Hunter